SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-20-007027
Filing Date
2020-02-27
Accepted
2020-02-27 07:47:03
Documents
83
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K atra-10k_20191231.htm   iXBRL 10-K 4063176
2 EX-1.1 atra-ex11_10.htm EX-1.1 206966
3 EX-4.4 atra-ex44_327.htm EX-4.4 34462
4 EX-5.1 atra-ex51_11.htm EX-5.1 17510
5 EX-10.22 atra-ex1022_255.htm EX-10.22 39943
6 EX-10.23 atra-ex1023_254.htm EX-10.23 26666
7 EX-10.24 atra-ex1024_253.htm EX-10.24 285084
8 EX-21.1 atra-ex211_7.htm EX-21.1 5800
9 EX-23.1 atra-ex231_6.htm EX-23.1 2459
10 EX-31.1 atra-ex311_12.htm EX-31.1 16192
11 EX-31.2 atra-ex312_9.htm EX-31.2 16190
12 EX-32.1 atra-ex321_13.htm EX-32.1 9539
13 GRAPHIC guj5vlzzbtzr000001.jpg GRAPHIC 28720
14 GRAPHIC g1zb32i00nob000002.jpg GRAPHIC 36635
15 GRAPHIC g1zb32i00nob000003.jpg GRAPHIC 20691
16 GRAPHIC g1zb32i00nob000001.jpg GRAPHIC 34683
  Complete submission text file 0001564590-20-007027.txt   13667251

Data Files

Seq Description Document Type Size
17 XBRL TAXONOMY EXTENSION SCHEMA atra-20191231.xsd EX-101.SCH 64350
18 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atra-20191231_cal.xml EX-101.CAL 86289
19 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atra-20191231_def.xml EX-101.DEF 182279
20 XBRL TAXONOMY EXTENSION LABEL LINKBASE atra-20191231_lab.xml EX-101.LAB 569851
21 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atra-20191231_pre.xml EX-101.PRE 403076
53 EXTRACTED XBRL INSTANCE DOCUMENT atra-10k_20191231_htm.xml XML 2528527
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36548 | Film No.: 20658512
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences